Tyra Biosciences: Wedbush raises target price to $57 from $53
TYRA•Wedbush raised its target price for Tyra Biosciences to $57 from $53.
Related News
Genprex presents diabetes gene therapy delivery strategy at symposium
GNPX•
Merlin wins $500,000 U.S. Africa Command contract for autonomous casualty evacuation demo
MRLN•
TIC Solutions outlines plans for $100 million-$150 million in annual acquisition spending
TIC•
Kodiak Gas Services sees upside to historical high single-digit EBITDA growth
KGS•
Advent Software sees wealth transfer to women reshaping wealth management priorities
SSNC•